John M. Maraganore
2013
In 2013, John M. Maraganore earned a total compensation of $6.2M as Chief Executive Officer principal executive officer at Alnylam Pharmaceuticals, a 158% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $431,828 |
|---|---|
| Option Awards | $5,127,198 |
| Salary | $669,500 |
| Other | $7,596 |
| Total | $6,236,122 |
Maraganore received $5.1M in option awards, accounting for 82% of the total pay in 2013.
Maraganore also received $431.8K in non-equity incentive plan, $669.5K in salary and $7.6K in other compensation.
Rankings
In 2013, John M. Maraganore's compensation ranked 940th out of 12,286 executives tracked by ExecPay. In other words, Maraganore earned more than 92.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 940 out of 12,286 | 92nd |
Division Manufacturing | 311 out of 4,612 | 93rd |
Major group Chemicals And Allied Products | 83 out of 1,462 | 94th |
Industry group Drugs | 50 out of 1,156 | 96th |
Industry Pharmaceutical Preparations | 44 out of 890 | 95th |
Source: SEC filing on March 17, 2016.
Maraganore's colleagues
We found four more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2013.
2013
Barry Greene
Alnylam Pharmaceuticals
Chief Operating Officer
2013
Akshay Vaishnaw
Alnylam Pharmaceuticals
Chief Medical Officer
2013
Laurence Reid
Alnylam Pharmaceuticals
Senior Vice President and Chief Business Officer
2013
Michael Mason
Alnylam Pharmaceuticals